読む Takara Bio to Present Clinical Data of Oncolytic Virus C-REV and NY-ESO-1・siTCR Gene Therapy at ASCO 2019
読む A wholly-owned subsidiary, Takara Biotechnology (Dalian) Co., Ltd.
Acquires ISO:13485 certification
読む Takara Bio to Acquire an Exclusive License to Use Patent Technology Relating to New Generation CAR Gene Therapy
読む Joint Research on New Development of CAR Gene Therapy
with Mie University
読む Joint Research on Novel Approach to Cancer Immune and Gene Therapy
with Department of Immunotherapeutics, The University of Tokyo Hospital